United Therapeutics | UTHR - Trade Debtors


United Therapeutics reported $310.3M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Amarin USD 126.83M 477K Dec/2025
Ardelyx USD 82.84M 10.99M Mar/2026
Baxter International USD 1.86B 158M Jun/2026
Bayer EUR 18.7B 146M Jun/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Insmed USD 215.32M 36.77M Jun/2026
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Lexicon Pharmaceuticals USD 2.38M 50K Dec/2025
Moderna USD 17M 54M Jun/2026
Omeros USD 8.08M 440K Jun/2024
Pfizer USD 16.19B 19M Jun/2026
PTC Therapeutics USD 219.92M 38.3M Mar/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
Teva Pharmaceutical Industries USD 3.49B 100M Jun/2026
United Therapeutics USD 310.3M 1.7M Jun/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026